← Back to Search

Interoceptive Exposure for Eating Disorders

N/A

Recruiting

Led By Thomas Hildebrandt, PsyD

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 18-months

Awards & highlights

Study Summary

This trial will compare two psychological treatments for eating disorders to see which works best for improving body weight & clinical impairment. It'll also study how these treatments work.

Who is the study for?

This trial is for English-speaking adolescents aged 12-18 with low weight eating disorders like anorexia. They must have a doctor's permission for outpatient care, show significant food intake restriction or avoidance, and be unable to maintain a healthy body weight. Those with substance dependence, bipolar/psychotic disorders, recent psychiatric medication changes, major medical illnesses, or active suicidal thoughts cannot join.Check my eligibility

What is being tested?

The study compares two psychological treatments: Interoceptive Exposure-based Family Therapy (IE) and standard Family-Based Treatment (FBT). It aims to see which treatment better helps teens reach expected body weight without clinical impairment over a year. The study also looks at how these therapies work by focusing on autonomous eating habits, non-judgmental body awareness, and learning to overcome fear responses related to eating.See study design

What are the potential side effects?

Since the interventions are psychological treatments rather than medications, typical drug side effects are not expected. However, participants may experience emotional discomfort or increased anxiety as they confront fears related to food intake and body image during therapy sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 18-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 18-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 18-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Expected Body Weight Percentage

Change in Impairment

Secondary outcome measures

Change in Autonomous Eating

Change in Eating Disorder Symptoms

Change in Food Cue Learning

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Interoceptive Exposure Treatment (IE)Experimental Treatment1 Intervention

Interoceptive Exposure Therapy (IE) targets food avoidance, food exposure, and body image exposure.

Group II: Family-Based Treatment (FBT)Active Control1 Intervention

Family-Based Therapy (FBT) focuses on parent-enforced contingencies, increasing value of eating, and decreasing the value of food avoidance.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH

2,786 Previous Clinical Trials

2,689,589 Total Patients Enrolled

47 Trials studying Anorexia Nervosa

22,723 Patients Enrolled for Anorexia Nervosa

Icahn School of Medicine at Mount SinaiLead Sponsor

862 Previous Clinical Trials

525,506 Total Patients Enrolled

5 Trials studying Anorexia Nervosa

206 Patients Enrolled for Anorexia Nervosa

Thomas Hildebrandt, PsyDPrincipal Investigatortom.hildebrandt@mssm.edu

1 Previous Clinical Trials

600 Total Patients Enrolled

Media Library

Family-Based Treatment (FBT) Clinical Trial Eligibility Overview. Trial Name: NCT05763849 — N/A

Anorexia Nervosa Research Study Groups: Interoceptive Exposure Treatment (IE), Family-Based Treatment (FBT)

Anorexia Nervosa Clinical Trial 2023: Family-Based Treatment (FBT) Highlights & Side Effects. Trial Name: NCT05763849 — N/A

Family-Based Treatment (FBT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05763849 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research program accept participants who are older than 55?

"This trial has a specific age range requirement; participants must be between the ages of 12 and 18. Furthermore, there are 67 trials for individuals below 18 years old and 68 studies with volunteers older than 65."

Answered by AI

What are the eligibility criteria for participation in this investigation?

"Potential participants of this trial must be between the ages of 12 and 18, suffering from anorexia nervosa. There is a total number of 120 people desired for enrollment."

Answered by AI

Are there any vacancies available for participants in this experiment?

"Currently, this medical trial is not engaging in the recruitment of patients. The initial post was on March 1st 2023 and has been revised up to February 28th 2023. Even though there are no open enrolment opportunities for this study right now, 153 other clinical trials have begun accepting participants already."

Answered by AI

What are the chief aims of this medical trial?

"The principal objective of this trial, measured over a Baseline and 18-month period, is to gauge any alterations in Impairment. Secondary objectives include gauging the transformation of Food Cue Learning (assessing how much disgust an individual will feel towards certain food items), Nonjudgmental Body Awareness (a questionnaire which evaluates one's understanding of their body sensitivity) as well as Eating disorder Symptoms (measuring psychopathological qualities related to eating disorders)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Interoceptive Exposure for Adolescents With Low Weight Eating Disorders

Tom Hildebrandt 2023. "Interoceptive Exposure for Adolescents With Low Weight Eating Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05763849.

All > Anorexia Nervosa > Eating Disorder